Frazier Life Sciences Management L.P. Sells 1,192,448 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Frazier Life Sciences Management L.P. cut its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 75.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 397,483 shares of the company’s stock after selling 1,192,448 shares during the quarter. Frazier Life Sciences Management L.P.’s […]

Related Keywords

Piper Sandler ,Stephenf Betz ,Marc Wilson ,News Ratings For Crinetics Pharmaceuticals Daily ,Citigroup ,Rafferty Asset Management ,Frazier Life Sciences Management ,Crinetics Pharmaceuticals ,Insider Transactions At Crinetics Pharmaceuticals ,Securities Exchange Commission ,Morgan Stanley ,Crinetics Pharmaceuticals Trading Down ,Nasdaq ,Quarter For Crinetics Pharmaceuticals ,First Light Asset Management ,Crinetics Pharmaceuticals Inc ,Investment Management ,Free Report ,Light Asset Management ,Eight Capital ,Point Capital ,Asset Management ,Exchange Commission ,Pharmaceuticals Trading Down ,Get Free Report ,Visit Holdingschannel ,Crinetics Pharmaceuticals Daily ,